These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Circumcision status and HIV infection among MSM: reanalysis of a Phase III HIV vaccine clinical trial. Gust DA; Wiegand RE; Kretsinger K; Sansom S; Kilmarx PH; Bartholow BN; Chen RT AIDS; 2010 May; 24(8):1135-43. PubMed ID: 20168206 [TBL] [Abstract][Full Text] [Related]
44. Current progress in HIV vaccines. Westblom TU; Belshe RB; Gorse GJ Mo Med; 1991 Nov; 88(11):762-5. PubMed ID: 1805131 [No Abstract] [Full Text] [Related]
45. HIV vaccine efficacy trials: towards the future of HIV prevention. Kim D; Elizaga M; Duerr A Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236 [TBL] [Abstract][Full Text] [Related]
46. HIV vaccine may raise risk. Ledford H Nature; 2007 Nov; 450(7168):325. PubMed ID: 18004331 [No Abstract] [Full Text] [Related]
47. HIV vaccine reduces infection rate by a third, study shows. Mayor S BMJ; 2009 Sep; 339():b3963. PubMed ID: 19783576 [No Abstract] [Full Text] [Related]
50. Human vaccine testing set. AIDS Patient Care STDS; 1998 Mar; 12(3):231. PubMed ID: 11361942 [No Abstract] [Full Text] [Related]
51. Preparing for phase II/III HIV vaccine trials in Africa. Vardas E; Buttò S; Glashoff R; Malnati MS; Poli G; Clerici M Microbes Infect; 2005 Nov; 7(14):1436-44. PubMed ID: 16257561 [TBL] [Abstract][Full Text] [Related]
52. New institute to focus on AIDS vaccine. AIDS Read; 2008 Nov; 18(11):551. PubMed ID: 19058408 [No Abstract] [Full Text] [Related]
53. Development of prophylactic AIDS vaccines: the current state of affairs. Hanke T Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467 [TBL] [Abstract][Full Text] [Related]
54. Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults. Nitayaphan S; Pitisuttithum P; Karnasuta C; Eamsila C; de Souza M; Morgan P; Polonis V; Benenson M; VanCott T; Ratto-Kim S; Kim J; Thapinta D; Garner R; Bussaratid V; Singharaj P; el-Habib R; Gurunathan S; Heyward W; Birx D; McNeil J; Brown AE; J Infect Dis; 2004 Aug; 190(4):702-6. PubMed ID: 15272397 [TBL] [Abstract][Full Text] [Related]
55. AIDS vaccine may offer hope only for some ethnic groups. Eaton L BMJ; 2003 Mar; 326(7387):463. PubMed ID: 12609919 [No Abstract] [Full Text] [Related]
56. Funding support lacking in search for HIV vaccine. AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091 [TBL] [Abstract][Full Text] [Related]
57. Building and testing an effective HIV vaccine. Kahn J West J Med; 1999; 171(5-6):363-5. PubMed ID: 10639877 [No Abstract] [Full Text] [Related]
58. Vaccines for control of HIV infections. Sharma KB J Indian Med Assoc; 1994 Jan; 92(1):27-8. PubMed ID: 8207277 [No Abstract] [Full Text] [Related]
59. HIV immunology: what lessons can we learn from recent vaccine trials? Kelleher P J HIV Ther; 2010 Mar; 15(1):2-5. PubMed ID: 21180231 [No Abstract] [Full Text] [Related]
60. Mapping the future of HIV vaccines. Nabel GJ Nat Rev Microbiol; 2007 Jul; 5(7):482-4. PubMed ID: 17571457 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]